tokens: Eastern Cooperative Oncology Group performance status improved in 35 % of those patients with an initial value > 0 , whereas relief of at least 1 symptom without worsening of other symptoms was noted in 27 patients ( 55 %). The median time to progression was 16 weeks and the 1 - year survival rate was 33 %. Toxicity was mild .